A Study to Determine the Efficacy and Safety of Halobetasol Propionate Lotion 0.05% in Subjects With Plaque Psoriasis
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This is a double-blind, multicenter, vehicle-controlled, parallel group comparison study to
determine and compare the efficacy and safety of HBP Lotion 0.05% and Vehicle Lotion applied
twice daily for two weeks in subjects with moderate to severe plaque psoriasis. Eligible
subjects will be randomized (1:1) to one of two treatment groups - HBP Lotion 0.05% or
Vehicle Lotion. The maximum amount of test article to be applied per week should not exceed
50 grams.